1.Hyder JA., Allison MA., Criqui MH., Wright CM. Association between systemic calcified atherosclerosis and bone density. Calcif Tissue Int. 2007. 80(5):301–6.
Article
2.Frye MA., Melton LJ 3rd., Bryant SC., Fitzpatrick LA., Wahner HW., Schwartz RS, et al. Osteoporosis and calcification of the aorta. Bone Miner. 1992. 19(2):185–94.
Article
3.Kado DM., Browner WS., Blackwell T., Gore R., Cummings SR. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res. 2000. 15(10):1974–80.
Article
4.Mussolino ME., Madans JH., Gillum RF. Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol. 2003. 13(10):692–7.
Article
5.Wang PS., Solomon DH., Mogun H., Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA. 2000. 283(24):3211–6.
Article
6.Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids. 2003. 68(6):373–8.
Article
7.Parhami F., Garfinkel A., Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol. 2000. 20(11):2346–8.
Article
8.Tankó LB., Bagger YZ., Nielsen SB., Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone. 2003. 32(1):8–14.
Article
9.Colles SM., Maxson JM., Carlson SG., Chisolm GM. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc Med. 2001. 11(3-4):131–8.
Article
10.Johnston CC Jr., Hui SL., Witt RM., Appledorn R., Baker RS., Longcope C. Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab. 1985. 61(5):905–11.
Article
11.Rosen CJ., Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med. 2009. 122(5):409–14.
Article
12.Parhami F., Mody N., Gharavi N., Ballard AJ., Tintut Y., Demer LL. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res. 2002. 17(11):1997–2003.
Article
13.Parhami F., Morrow AD., Balucan J., Leitinger N., Watson AD., Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997. 17(4):680–7.
14.Buhaescu I., Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem. 2007. 40(9-10):575–84.
Article
15.Kim YH., Nam GE., Cho KH., Choi YS., Kim SM., Han BD, et al. Low bone mineral density is associated with dyslipidemia in South Korean men: the 2008-2010 Korean National Health and Nutrition Examination Survey. Endocr J. 2013. 60(10):1179–89.
Article
16.Rhee EJ., Kim SY., Jung CH., Lhee HY., Lee WY., Kim SW. The correlation between lumbar spine bone mineral density and serum lipid profiles in apparently healthy Korean males. J Korean Soc Osteoporosis. 2004. 2(2):105–11.
17.Suh YS. Relationship between bone mineral density and blood lipid in young and middle-aged men and pre-menopausal women. Korean J Health Promot. 2007. 7(4):238–44.
18.Solomon DH., Avorn J., Canning CF., Wang PS. Lipid levels and bone mineral density. Am J Med. 2005. 118(12):1414.
Article
19.Wu LY., Yang TC., Kuo SW., Hsiao CF., Hung YJ., Hsieh CH, et al. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res. 2003. 29(3):317–25.
Article
20.Adami S., Braga V., Zamboni M., Gatti D., Rossini M., Bakri J, et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int. 2004. 74(2):136–42.
Article
21.Dennison EM., Syddall HE., Aihie Sayer A., Martin HJ., Cooper C. Hertfordshire Cohort Study Group. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. QJM. 2007. 100(5):297–303.
Article
22.Hernández JL., Olmos JM., Ramos C., Martínez J., de Juan J., Valero C, et al. Serum lipids and bone metabolism in Spanish men: the Camargo cohort study. Endocr J. 2010. 57(1):51–60.
Article
23.Adami S., Braga V., Gatti D. Association between bone mineral density and serum lipids in men. JAMA. 2001. 286(7):791–2.
Article
24.Cui LH., Shin MH., Chung EK., Lee YH., Kweon SS., Park KS, et al. Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos Int. 2005. 16(12):1975–81.
Article
25.Zhao LJ., Liu YJ., Liu PY., Hamilton J., Recker RR., Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab. 2007. 92(5):1640–6.
Article
26.Lenchik L., Register TC., Hsu FC., Lohman K., Nicklas BJ., Freedman BI, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003. 33(4):646–51.
Article
27.Maurin AC., Chavassieux PM., Frappart L., Delmas PD., Serre CM., Meunier PJ. Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone. 2000. 26(5):485–9.
Article
28.Dragojevič J., Zupan J., Haring G., Herman S., Komadina R., Marc J. Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study. J Bone Miner Metab. 2013. 31(5):512–9.
Article
29.D'Amelio P., Pescarmona GP., Gariboldi A., Isaia GC. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause. 2001. 8(6):429–32.
30.Yamaguchi T., Sugimoto T., Yano S., Yamauchi M., Sowa H., Chen Q, et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr J. 2002. 49(2):211–7.
Article